Complete Wegovy vs Mounjaro Dose Comparison Guide
Wegovy Versus Mounjaro: Complete Dose Availability Advantage
When comparing Wegovy versus Mounjaro, one critical factor often overlooked is dose availability throughout your treatment journey. EverydayMeds stocks every single dose of both medications, ensuring you never face treatment interruption due to supply issues. Wegovy requires five distinct doses during escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and finally 2.4mg for maintenance from week 17 onwards. This comprehensive dose escalation is mandatory – you cannot skip doses safely.
The advantage of having all doses readily available becomes apparent when you consider that many pharmacies struggle with supply consistency, particularly for higher maintenance doses. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted long-term treatment. Whether you choose Wegovy (semaglutide, a GLP-1 receptor agonist) or Mounjaro (tirzepatide, a dual GIP and GLP-1 agonist), EverydayMeds becomes your single pharmacy partner from initiation through maintenance, eliminating the stress of finding alternative suppliers mid-treatment.
Wegovy Versus Mounjaro Pricing: Complete Cost Breakdown
Understanding the full cost implications when weighing Wegovy versus Mounjaro requires examining pricing across all dose levels. Wegovy single pen pricing progresses from £79.99 for the 0.25mg starter dose, £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, up to £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout to reach these prices, while returning customers use code DOSE25. Our bundle options provide convenience advantages, such as the Intro Duo combining 0.25mg and 0.5mg doses for £169.99, perfect for your first two months of treatment.
The Elevate Trio bundle, containing 1mg, 1.7mg, and 2.4mg doses for £499.99, covers your progression through months three to six of treatment. For patients requiring extended time at lower doses, our Take-It-Slow bundles accommodate individual tolerance levels – the Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99. This pricing transparency across the complete Wegovy versus Mounjaro comparison allows informed financial planning for your entire weight management journey, backed by GPhC registration #9012878.
Clinical Evidence: Wegovy Versus Mounjaro Trial Data
When examining Wegovy versus Mounjaro from a clinical perspective, both demonstrate significant efficacy in their respective trial programmes. Wegovy's STEP trials showed patients may achieve average weight loss of approximately 15% at 68 weeks when combined with diet and exercise, as documented by Wilding et al., NEJM, 2021. The SELECT trial further demonstrated a 20% reduction in major cardiovascular events among patients taking Wegovy.
Mounjaro's SURMOUNT trials indicate the dual GIP and GLP-1 mechanism may offer additional benefits, though direct head-to-head comparisons between the treatments haven't been conducted. Both medications require the same fundamental approach: prescription-only medicine status, mandatory dose escalation, and integration with reduced-calorie diet and increased physical activity for optimal results.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding the Wegovy versus Mounjaro mechanisms helps inform treatment choice, starting with how Wegovy functions as a GLP-1 receptor agonist. Wegovy mimics the natural hormone GLP-1, which your intestines release after eating to signal fullness to your brain. This mechanism may reduce appetite and promote satiety after smaller meals, potentially making it easier to maintain a reduced-calorie diet. The medication works on specific brain centres that control appetite and food cravings, which may explain why many patients report reduced interest in high-calorie foods. Unlike Mounjaro's dual mechanism targeting both GIP and GLP-1 receptors, Wegovy focuses specifically on the GLP-1 pathway. The once-weekly injection using the FlexTouch pen provides consistent medication levels throughout the week, supporting sustained appetite management.
Ordering Process: From Assessment to Delivery
Accessing either medication in the Wegovy versus Mounjaro comparison begins with our streamlined 3-minute online clinical assessment. This assessment captures essential medical history, current medications, and weight management goals to ensure prescription safety and suitability. Following submission, our prescribers review your assessment within 3 working days as standard, or within 24 hours with our express service for urgent requirements. Once approved, your medication ships via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C storage temperature. All deliveries are temperature-monitored and require signature on receipt to ensure medication integrity. This process applies whether you're starting with a single 0.25mg pen or ordering our comprehensive bundle options for extended treatment periods.
Storage and Practical Considerations
Practical storage differences form an important part of the Wegovy versus Mounjaro evaluation, particularly for patients who travel frequently. Wegovy can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature tolerance provides greater flexibility for holidays or business travel. The FlexTouch pen design used for Wegovy delivery is pre-filled and disposable, requiring no mixing or preparation – simply attach a new needle for each injection. Dose escalation must follow the prescribed schedule: four weeks each at 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. Missing doses or attempting to accelerate the escalation schedule may increase side effect risks and reduce treatment effectiveness.
Comprehensive Treatment Journey: Wegovy Versus Mounjaro Planning
The Wegovy versus Mounjaro decision extends beyond initial prescription to encompass your entire treatment timeline, making comprehensive dose availability crucial for success. Most patients require 16 weeks to reach maintenance dosing, followed by indefinite continuation for sustained results. STEP trial extensions revealed that patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising the importance of long-term medication access.
Our bundle structure supports this reality, with options like the Progress Trio covering months two through four with 0.5mg, 1mg, and 1.7mg doses for £369.99. For maintenance phase patients, the Ultimate Stability Trio ensures three months of 2.4mg supply without interruption. This comprehensive approach eliminates the common problem of treatment discontinuation due to supply shortages at critical transition points between doses.
Access Your Complete Treatment Today
Both Wegovy and Mounjaro are available from EverydayMeds with complete dose ranges in stock, allowing your prescriber to help determine which treatment aligns best with your individual needs and medical history. Start your clinical assessment today to access either medication, with new customer discount code FIRST40 applied at checkout for immediate savings. Our GPhC-registered pharmacy (#9012878) ensures legitimate supply of these prescription-only medicines with full prescriber oversight and cold-chain delivery nationwide. Whether you choose Wegovy's proven GLP-1 mechanism or are considering Mounjaro's dual approach, EverydayMeds provides the complete treatment pathway from initiation through long-term maintenance. Begin your assessment now and discover which treatment may help support your weight management goals alongside diet and exercise modifications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
